Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Clinical Trials
Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing development of its fetal pulse oximetry technology. The study evaluates Raydiant’s...

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Clinical Trials
Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical

Mergers & Acquisitions
Spectrum Vascular has acquired Piccolo Medical, a developer of FDA-cleared catheter guidance technology, in a move aimed at strengthening its vascular access offerings. The acquisition...

Nyxoah secures $110M financing to accelerate U.S. launch of Genio

Funding
Nyxoah has secured $110 million in new capital to support the U.S. commercial expansion of its Genio implantable therapy for obstructive sleep apnea (OSA). The...

GS MedTech Funding Tracker – Novanta, CeQur, and more

GS Funding Tracker
Big capital and early innovation met this week in MedTech, with major financings in commercial-stage platforms and continued backing for emerging device and digital...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Innovation

Regulatory Approvals

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical

Spectrum Vascular has acquired Piccolo Medical, a developer of FDA-cleared catheter guidance technology, in a move aimed at strengthening its vascular access offerings. The acquisition...

Nyxoah secures $110M financing to accelerate U.S. launch of Genio

Nyxoah has secured $110 million in new capital to support the U.S. commercial expansion of its Genio implantable therapy for obstructive sleep apnea (OSA). The...

GS MedTech Funding Tracker – Novanta, CeQur, and more

Big capital and early innovation met this week in MedTech, with major financings in commercial-stage platforms and continued backing for emerging device and digital...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1155Regulatory Approvals1024Innovation655Clinical Trials527Mergers & Acquisitions511GS Funding Tracker53